3,000
Participants
Start Date
January 8, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Hepatitis C virus self-test (oral fluid HCVST)
"The participant will be able to choose between oral-fluid or blood-based HCVST. The package will include an HCV OraQuick ® HCV Self-Test kit, (OraSure Technologies, Inc, Bethlehem, PA) or a Wondfo® HCV Self-Test (Guangzhou, P.R. China) at Primary Study.~At Ancyllary study, the individuals attending PrEP consultations at INI/FIOCRUZ will be invited to perform HCVST using blood-based and oral-fluid kits."
Hepatitis C virus self-test (blood-based HCVST)
The participant will be able to choose between oral-fluid or blood-based HCVST. The package will include an HCV OraQuick ® HCV Self-Test kit, (OraSure Technologies, Inc, Bethlehem, PA) or a Wondfo® HCV Self-Test (Guangzhou, P.R. China) at Primary Study. At Ancylary Study, the individuals attending PrEP consultations at INI/FIOCRUZ will be invited to perform HCVST using blood-based and oral-fluid kits.
Evandro Chagas National Institute of Infectious Diseases, Rio de Janeiro
World Health Organization
OTHER
UNITAID
OTHER
Oswaldo Cruz Foundation
OTHER